Page last updated: 2024-09-04

docetaxel anhydrous and 1-hydroxymethylmidazolam

docetaxel anhydrous has been researched along with 1-hydroxymethylmidazolam in 1 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010)
(docetaxel anhydrous)
Studies
(1-hydroxymethylmidazolam)
Trials
(1-hydroxymethylmidazolam)
Recent Studies (post-2010) (1-hydroxymethylmidazolam)
12,1103,2166,9201634649

Protein Interaction Comparison

ProteinTaxonomydocetaxel anhydrous (IC50)1-hydroxymethylmidazolam (IC50)
Cytochrome P450 3A4Homo sapiens (human)10
5-hydroxytryptamine receptor 2ARattus norvegicus (Norway rat)10

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, X; Deng, S; Fan, A; Gao, W; Li, C; Li, N; Liu, Q; Wang, C; Wen, X; Zhang, Q; Zhang, W; Zhang, Y; Zhao, D; Zhao, J1

Other Studies

1 other study(ies) available for docetaxel anhydrous and 1-hydroxymethylmidazolam

ArticleYear
Effect of triacontanol on the pharmacokinetics of docetaxel in rats associated with induction of cytochrome P450 3A1/2.
    Xenobiotica; the fate of foreign compounds in biological systems, 2014, Volume: 44, Issue:7

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Cytochrome P-450 CYP3A; Docetaxel; Enzyme Induction; Fatty Alcohols; Female; Gene Expression Regulation, Enzymologic; Male; Microsomes, Liver; Midazolam; Rats, Sprague-Dawley; Reproducibility of Results; Taxoids

2014